Moreover, EGCG modulates some signaling pathways (e.g., Hedgehog and AMPK/AKT/MAPK pathways) in human rhabdomyosarcoma cells and NSCLC to overcome drug resistance [534, 540, 541]. Here, AKT1 is linked to non-small cell lung carcinoma.